BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Bio-Interaction

Biotage CEO Discusses Astrea Bioseparations Acquisition and Expansion into Biopharma Sector

BioPharma APAC in an interaction with Tomas Blomquist, CEO and President of Biotage, to gain insights into the recent acquisition of Astrea Biosepara...

June 07, 2023 | News

Thermo Fisher Scientific Expands Sterile Drug Facility in Singapore, Strengthening Asia-Pacific BioPharma Market

Thermo Fisher Scientific, a global leader in serving science, announces the expansion of its sterile drug facility in Singapore, marking a significant mile...

June 02, 2023 | Influencers

Isabelle Lafosse-Marin Discusses Thermo Fisher Scientific's French Expansion, Ushering in a New Era of Drug Manufacturing Excellence.

Isabelle Lafosse-Marin, Senior Director and General Manager of Thermo Fisher Scientific's Bourgoin site, shed light on the company's expansion in Fra...

May 19, 2023 | News

Australia's First End-to-End mRNA CDMO Facility to Boost Vaccine Production and Research Capabilities

What is the significance of the first end-to-end mRNA process contract development and manufacturing organization (CDMO) establishment in Australia? ...

May 17, 2023 | News

Cytiva and Pall Life Sciences merge to form a comprehensive solutions provider for biotechnology challenges, with focus on innovation and digitalization

Discover how the combined technical expertise, talent, and portfolio offerings of these two distinguished brands are driving the next generation of medicin...

May 12, 2023 | News

Revolutionizing Drug Development: IQVIA's David Cameron on the Power of Innovative Trial Designs

Can you tell us about your role as Senior Director & Global Head of Novel Trial Design at IQVIA? The Novel Trial Design initiative at IQ...

May 09, 2023 | News

Emmes' Acquisition of Essex Management Boosts Its Technology Prowess to Help Solve Global Health Challenges

Biopharma APAC sat down with Matt Honan (MH), Vice president and global head of corporate development at Emmes and Ching Tian (CT), Chief In...

April 06, 2023 | Influencers

Podcast : Getting ÄKTA ready in virtual reality

Conor and Dodi try their hand at learning to operate an ÄKTA ready in virtual reality. Their virtual journey takes them to Singapore and Miami, withou...

April 05, 2023 | Opinion

Noxopharm CEO Discusses SOF-VAC™, a Promising Vaccine Enhancer for mRNA Vaccines

In an interaction with BioPharma APAC, Noxopharm CEO Dr. Gisela Mautner discussed the company's newly announced proprietary product candidate, SOF-VAC&trad...

March 31, 2023 | Influencers

Aptamer Group's Optimer-Fc: An Innovative Solution to Enhance Accuracy of Automated IHC Workflows

Aptamer Group's Chief Technical Officer, Dr David Bunka, speaks to BioPharma APAC about the innovative Optimer-Fc reagent solution for immunohistochemistry...

March 29, 2023 | Influencers

Eppendorf's commitment to customer-centric innovation: How the company stays ahead of the curve

BioPharma APAC organized a Women’s Leadership Series and interviewed a Eva van Pelt Co-CEO & Chief Commercial Officer Eppendorf SE, Hamburg, Germ...

March 21, 2023 | News

New Medium and Feeds System from Thermo Fisher Scientific Boosts CHO Cell Culture Performance

Thermo Fisher Scientific, a leading biotechnology company, recently provided expert insights into its new media and feed system, Gibco™ Effic...

March 21, 2023 | News

BRIM appoints Andrew Lin as Chairman and Dr. Wen Chyi Shyu as CEO, secures $18M in Series E funding, and advances clinical trials for Dry Eye Disease and Neurotrophic Keratitis treatments

What led to the decision to elect Andrew Lin as the new Chairman of the Board, and how do you believe he will contribute to BRIM's continued succ...

March 01, 2023 | Opinion

Oliver Healthcare Packaging expands presence in Asia Pacific with new manufacturing facility in Malaysia

Oliver Healthcare Packaging has announced plans to expand its presence in Asia Pacific with a new manufacturing facility in Malaysia, which is set to open ...

March 01, 2023 | Opinion

Stay Connected